Immunohistochemistry Market size was valued at USD 3.58 Billion in 2023 and the total Immunohistochemistry Market revenue is expected to grow at a CAGR of 7.5% from 2024 to 2030, reaching nearly USD 5.94 Billion by 2030.Immunohistochemistry Market Overview:
Using appropriately labeled antibodies that attach selectively to their target antigens in situ, immunohistochemistry (IHC) integrates anatomical, immunological, and biochemical approaches to scan discrete components in tissues. IHC enables the high-resolution distribution and localization of particular cellular components within cells and within their appropriate histological context to be seen and documented. IHC methodology allows for a variety of ways and combinations, but all of the stages are divided into two categories: sample preparation and sample staining. The market is expected to grow significantly through the forecast period amid rising automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions. The demand for IHC in disease diagnosis has increased significantly as a result of improvements in IHC methods. The market is also growing as a result of the rise in product approvals and the introduction of technologically sophisticated IHC equipment for illness diagnostics.To know about the Research Methodology:-Request Free Sample Report
Immunohistochemistry Market Dynamics:
1. The increasing geriatric population and high prevalence of chronic and infectious diseases: The aging population will have a significant impact on the growth of the IHC market in both developed and developing regions. The prevalence of age-related disorders is expected to surge considerably with the geriatric population's rapid growth. Other wealthy nations have sizable and growing senior populations as well. The chance of getting diseases rises proportionately with age. Therefore, it is expected that the prevalence of various diseases will rise significantly as the geriatric population grows. This is thought to be a major driver driving the IHC market for diagnostic applications. 2. New product launches in the market: Market development will be supported by key market leaders focusing more on technological developments in accordance with current needs. In the upcoming years, the market is expected to grow due to the introduction of new products in the immunohistochemistry sector to address the problems mentioned before. The markets leading players are developing cutting-edge technologies that are expected to fuel market growth. For instance, Biocare Medical announced the release of seven novel IVD IHC antibody markers in February 2020 for use in diagnostics and other research applications. The introduction of these clinical diagnostic markers might aid the immuno-oncology field in advancing early medication development for the treatment of cancer. 3. Growing need of Immunohistochemistry (IHC) for drug development: In the upcoming years, the market is expected to grow due to the rising frequency of chronic disorders. The market will grow and capture the most share in the near future due to the increase in patients with cancer, infectious diseases, and cardiovascular disorders where immunohistochemistry is utilized for diagnosis. The alarming rate at which infectious diseases are spreading is a challenge for medical professionals in the development of drugs for such unidentified diseases, and the rise in demand for treatments for such diseases will drive the market to a booming pace in the near future. Obesity rates have been rising quickly in both rich and emerging nations. The increase in the number of obese people is largely due to factors like unhealthy lifestyles and sedentary habits. A round 42% of the population, are expected to be obese. When compared to younger adults, middle-aged adults (44.7%) had a significantly higher frequency of obesity (38.7%). Healthcare costs have increased as a result of the rise in the number of obese people. 4. Increasing healthcare expenditure: Due to rising healthcare spending in developed nations and improving healthcare infrastructure, the biotechnology market is expected to have considerable growth through the forecast period. The market is expected to be driven by a rise in government financing for clinical research including in vitro molecular diagnostics, as these studies are essential to the creation of new products. Significant market growth has been fueled by rising investments in well-known biotech and biopharma businesses. Compared to the United States, Chinese investors are increasingly concentrating on funding European biotech firms. Medication development, production, and distribution are all handled by the pharmaceutical sector. In the last 20 years, the market has grown significantly, and in 2021, total pharma revenues reached USD 1.42 trillion. It is growing with a CAGR of 11.5%.Immunohistochemistry Market Restraints: The immunohistochemistry market's growth is being limited by the lack of specificity in techniques and expensive setup costs. The absence of IHC techniques needed for the diagnosis of several chronic diseases poses a hurdle to the market. A considerable burden of high setup costs for automated Immunohistochemistry devices in the diagnostic labs of emerging nations is one of the other obstacles preventing market growth. Over the course of the assessment period, it has stifled market growth. However, it is expected that the healthcare market will undergo a profound transformation and enter a phase of market growth. Immunohistochemistry Market Opportunities: 1. Growing demand for personalized medicine: The usage of personalized medicine is expected to grow in the future due to its extraordinary efficacy in treating non-small-cell lung cancer patients. This method of choosing a course of treatment is backed by immunohistochemistry procedures, which carry out the most thorough and precise histological subtyping of malignancies (supported by predictive immunohistochemistry and the assessment of relevant biomarkers). A beneficial substitute or addition to molecular testing is the increased accessibility of immunohistochemical assays that identify mutant proteins, such as BRAF V600E and IDH1 R132H. These methods are useful new instruments in the treatment of cancer in the current era since they are highly reproducible, involve a manageable level of technical and interpretive complexity, and are substantially less expensive. Immunohistochemistry Market Challenges: 1. lack of qualified professionals: Because cancer is becoming more common, there is a large increase in the demand for pathology services for clinical applications. Most of the examinations carried out on cancer patients use histopathology technology. However, these laboratories are severely short on trained personnel. A tiny number of histopathologists are being trained, and many histopathologists have reached retirement age. However, with a limited staff, laboratories are under pressure to process a growing number of specimens.
Immunohistochemistry Market Segment Analysis:
Based on Product, the Immunohistochemistry Market is segmented into Antibodies, Equipment, Reagents, and Kits. Due to the crucial role that antibodies play in illness diagnosis and medication testing, the antibodies segment dominated the market in 2023 and accounted for more than XX% share. In terms of usage rate, monoclonal antibodies, and related products such as Fc-fusion, antibody fragments, and antibody-drug conjugates have taken the lead. The antibodies are used in a variety of fields, including neuropathology, hematopathology, and pathology. Through the forecast period, the kits category is expected to grow at the quickest CAGR. The selection process for the use of an acceptable combination of antibodies and stains against a tissue sample is eliminated when using kits, which significantly decreases the amount of work required during the IHC procedure. This market is expected to be driven by the products' compact design and user-friendliness.Based on the End-User, the Immunohistochemistry Market is segmented into Hospitals and Diagnostic Laboratories, and academic and research Institutes. Revenues from the Hospitals and Diagnostic Laboratories category, which are dominating the market share, are expected to grow rapidly at a CAGR of XX% through the forecast period due to the increasing use of diagnostic instruments. The hospital and diagnostic lab end-user sectors account for more than XX% of the total revenue. This growth is related to the large number of IHC tests performed in medical facilities. Furthermore, the need for hospitals with cutting-edge facilities has grown because of the healthcare sector's ongoing changes. In consequence, it is expected that this will increase this segment's revenue flow.
Immunohistochemistry Market Regional Insights:
The North America region dominated the market with a XX% share in 2023. The North America region is expected to witness significant growth at a CAGR of XX% through the forecast period. The presence of significant market participants, the ease with which IHC solutions are accessible, the increased use of technologically advanced IHC instruments, and the arrival of newer IHC solutions are important factors influencing the growth of the regional market. The U.S. is the fastest-growing country in the North America region growing with a CAGR of XX% through the forecast period. Asia Pacific region is the fastest-growing region, and it is expected to grow at a CAGR of around XX% through the forecast period. The multinational players' increased geographic presence in the Asian markets is mostly too accountable for this. Additionally, a huge patient base in nations like China and India offers a high number of clinical subjects for IHC R&D tests, which boosts income. Japan, South Korea, and India are the leading countries with the highest CAGR the in Asia Pacific region. They are expected to grow at a CAGR of 10.8%, 9.5%, and 8.6% respectively. The objective of the report is to present a comprehensive analysis of the global Immunohistochemistry Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Immunohistochemistry Market dynamic, structure by analyzing the market segments and projecting the Immunohistochemistry Market size. Clear representation of competitive analysis of key players by Product type, price, financial position, product portfolio, growth strategies, and regional presence in the Immunohistochemistry Market make the report investor’s guide.Immunohistochemistry Industry Ecosystem
Immunohistochemistry Market Scope: Inquire before buying
Global Immunohistochemistry Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 3.58 Bn Forecast Period 2024 to 2030 CAGR: 7.5% Market Size in 2030: USD 5.94 Bn Segments Covered: by Product Antibodies Equipment Reagents Kits by Application Diagnostics Application Cancer Infectious Diseases Cardiovascular Diseases Autoimmune Diseases Diabetes Mellitus Nephrological Diseases Research Application Forensic Application by End-User Hospitals & Diagnostic Laboratories Academic & Research Institutes Other Immunohistochemistry Market by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Immunohistochemistry Market Key Players
1. F. Hoffman-La Roche AG (Switzerland) 2. Danaher Corporation (US) 3. Agilent Technologies, Inc. (US) 4. Merck KGaA (Germany) 5. Bio-Rad Laboratories, Inc. (US) 6. Bio-Techne Corporation (US) 7. Abcam plc (UK) 8. Becton Dickinson and Company (US) 9. PerkinElmer, Inc. (US) 10. Takara Bio, Inc. (Japan) 11. Thermo Fisher Scientific, Inc. (US) 12. PHC Holdings Corporation (Japan) 13. Cell Signaling Technology, Inc. (US) 14. Bio SB, Inc. (US) 15. Miltenyi Biotec (Germany) 16. CANDOR Bioscience GmbH (Germany) 17. Sakura Finetek Japan Co., Ltd. (Japan) 18. Eagle Biosciences, Inc. (US) 19. Biocare Medical, LLC (US)Frequently Asked Questions:
1. What segments are covered in the Global Immunohistochemistry Market report? Ans. The segments covered in the Immunohistochemistry Market report are based on Product, Application, and End User. 2. Which region is expected to hold the highest share in the Global Immunohistochemistry Market? Ans. The North America region is expected to hold the highest share of the Immunohistochemistry Market. 3. What is the market size of the Global Immunohistochemistry Market by 2030? Ans. The market size of the Immunohistochemistry Market by 2030 is expected to reach USD 5.94 Bn. 4. What is the forecast period for the Global Immunohistochemistry Market? Ans. The forecast period for the Immunohistochemistry Market is 2024-2030. 5. What was the market size of the Global Immunohistochemistry Market in 2023? Ans. The market size of the Immunohistochemistry Market in 2023 was valued at USD 3.58 Bn.
1. Immunohistochemistry Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Immunohistochemistry Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Business Segment 2.4.3. End-user Segment 2.4.4. Growth Rate (Y-O-Y %) 2.4.5. Revenue (2023) 2.4.6. Profit Margin 2.4.7. Market Share 2.4.8. Key Development 2.5. Market Size Estimation Methodology 2.5.1. Bottom-Up Approach 2.5.2. Top-Down Approach 2.6. Industry Ecosystem 2.6.1. Role of Raw Material Suppliers 2.6.2. Role of Product Providers 2.6.3. Manufacturing 2.6.4. Logistics and Post-Sales 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Mergers and Acquisitions Details 3. Immunohistochemistry Market: Dynamics 3.1. Immunohistochemistry Market Trends 3.2. Immunohistochemistry Market Dynamics 3.2.1.1. Drivers 3.2.1.2. Restraints 3.2.1.3. Opportunities 3.2.1.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Customer Bargaining Power 3.3.2. Supplier Bargaining Power 3.3.3. Threat of New Entrants 3.3.4. Rivalry of Competitors 3.3.5. Threat of Substitute Products 3.4. PESTLE Analysis 3.5. Regulatory Landscape By Region 3.5.1. Regulations Related to Immunohistochemistry Market 3.5.2. Regulatory Bodies, Government Agencies, and Other Organizations 3.6. Key Opinion Leader Analysis for the Immunohistochemistry Industry 3.7. Technology Analysis 3.7.1. Automated Immunohistochemistry Systems 3.7.2. Multiplex Immunohistochemistry 3.7.3. Chromogenic Detection 3.7.4. Fluorescent Detection 3.8. Impact of AI on Immunohistochemistry Market 4. Immunohistochemistry Market: Global Market Size and Forecast By Segmentation (By Value in USD Mn) (2023-2030) 4.1. Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 4.1.1. Antibodies 4.1.2. Equipment 4.1.3. Reagents 4.1.4. Kits 4.2. Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 4.2.1. Diagnostics Application 4.2.1.1. Cancer 4.2.1.2. Infectious Diseases 4.2.1.3. Cardiovascular Diseases 4.2.1.4. Autoimmune Diseases 4.2.1.5. Diabetes Mellitus 4.2.1.6. Nephrological Diseases 4.2.2. Research Application 4.2.3. Forensic Application 4.3. Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 4.3.1. Hospitals & Diagnostic Laboratories 4.3.2. Academic & Research Institutes 4.3.3. Other 5. North America Immunohistochemistry Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 5.1. North America Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 5.1.1. Antibodies 5.1.2. Equipment 5.1.3. Reagents 5.1.4. Kits 5.2. North America Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 5.2.1. Diagnostics Application 5.2.1.1. Cancer 5.2.1.2. Infectious Diseases 5.2.1.3. Cardiovascular Diseases 5.2.1.4. Autoimmune Diseases 5.2.1.5. Diabetes Mellitus 5.2.1.6. Nephrological Diseases 5.2.2. Research Application 5.2.3. Forensic Application 5.3. North America Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 5.3.1. Hospitals & Diagnostic Laboratories 5.3.2. Academic & Research Institutes 5.3.3. Other 5.4. North America Immunohistochemistry Market Size and Forecast, By Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 5.4.1.1.1. Antibodies 5.4.1.1.2. Equipment 5.4.1.1.3. Reagents 5.4.1.1.4. Kits 5.4.1.2. United States Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 5.4.1.2.1. Diagnostics Application 5.4.1.2.1.1. Cancer 5.4.1.2.1.2. Infectious Diseases 5.4.1.2.1.3. Cardiovascular Diseases 5.4.1.2.1.4. Autoimmune Diseases 5.4.1.2.1.5. Diabetes Mellitus 5.4.1.2.1.6. Nephrological Diseases 5.4.1.2.2. Research Application 5.4.1.2.3. Forensic Application 5.4.1.3. United States Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 5.4.1.3.1. Hospitals & Diagnostic Laboratories 5.4.1.3.2. Academic & Research Institutes 5.4.1.3.3. Other 5.4.2. Canada 5.4.2.1. Canada Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 5.4.2.1.1. Antibodies 5.4.2.1.2. Equipment 5.4.2.1.3. Reagents 5.4.2.1.4. Kits 5.4.2.2. Canada Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 5.4.2.2.1. Diagnostics Application 5.4.2.2.1.1. Cancer 5.4.2.2.1.2. Infectious Diseases 5.4.2.2.1.3. Cardiovascular Diseases 5.4.2.2.1.4. Autoimmune Diseases 5.4.2.2.1.5. Diabetes Mellitus 5.4.2.2.1.6. Nephrological Diseases 5.4.2.2.2. Research Application 5.4.2.2.3. Forensic Application 5.4.2.3. Canada Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 5.4.2.3.1. Hospitals & Diagnostic Laboratories 5.4.2.3.2. Academic & Research Institutes 5.4.2.3.3. Other 5.4.3. Mexico 5.4.3.1. Mexico Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 5.4.3.1.1. Antibodies 5.4.3.1.2. Equipment 5.4.3.1.3. Reagents 5.4.3.1.4. Kits 5.4.3.2. Mexico Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 5.4.3.2.1. Diagnostics Application 5.4.3.2.1.1. Cancer 5.4.3.2.1.2. Infectious Diseases 5.4.3.2.1.3. Cardiovascular Diseases 5.4.3.2.1.4. Autoimmune Diseases 5.4.3.2.1.5. Diabetes Mellitus 5.4.3.2.1.6. Nephrological Diseases 5.4.3.2.2. Research Application 5.4.3.2.3. Forensic Application 5.4.3.3. Mexico Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 5.4.3.3.1. Hospitals & Diagnostic Laboratories 5.4.3.3.2. Academic & Research Institutes 5.4.3.3.3. Other 6. Europe Immunohistochemistry Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 6.1. Europe Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.2. Europe Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.3. Europe Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4. Europe Immunohistochemistry Market Size and Forecast, By Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.1.2. United Kingdom Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.1.3. United Kingdom Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.2. France 6.4.2.1. France Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.2.2. France Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.2.3. France Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.3. Germany 6.4.3.1. Germany Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.3.2. Germany Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.3.3. Germany Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.4. Italy 6.4.4.1. Italy Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.4.2. Italy Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.4.3. Italy Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.5. Spain 6.4.5.1. Spain Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.5.2. Spain Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.5.3. Spain Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.6.2. Sweden Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.6.3. Sweden Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.7. Austria 6.4.7.1. Austria Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.7.2. Austria Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.7.3. Austria Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 6.4.8.2. Rest of Europe Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 6.4.8.3. Rest of Europe Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7. Asia Pacific Immunohistochemistry Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 7.1. Asia Pacific Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.2. Asia Pacific Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.3. Asia Pacific Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4. Asia Pacific Immunohistochemistry Market Size and Forecast, By Country (2023-2030) 7.4.1. China 7.4.1.1. China Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.1.2. China Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.1.3. China Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.2.2. S Korea Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.2.3. S Korea Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.3. Japan 7.4.3.1. Japan Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.3.2. Japan Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.3.3. Japan Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.4. India 7.4.4.1. India Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.4.2. India Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.4.3. India Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.5. Australia 7.4.5.1. Australia Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.5.2. Australia Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.5.3. Australia Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.6.2. Indonesia Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.6.3. Indonesia Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.7.2. Malaysia Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.7.3. Malaysia Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.8.2. Vietnam Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.8.3. Vietnam Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.9.2. Taiwan Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.9.3. Taiwan Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 7.4.10.2. Rest of Asia Pacific Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 7.4.10.3. Rest of Asia Pacific Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 8. South America Immunohistochemistry Market Size and Forecast By Segmentation (By Value in USD Million) (2023-2030) 8.1. South America Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 8.2. South America Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 8.3. South America Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 8.4. South America Immunohistochemistry Market Size and Forecast, By Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 8.4.1.2. Brazil Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 8.4.1.3. Brazil Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 8.4.2.2. Argentina Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 8.4.2.3. Argentina Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 8.4.3.2. Rest of South America Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 8.4.3.3. Rest of South America Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 9. Middle East and Africa Immunohistochemistry Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 9.1. Middle East and Africa Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 9.2. Middle East and Africa Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 9.3. Middle East and Africa Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 9.4. Middle East and Africa Immunohistochemistry Market Size and Forecast, By Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 9.4.1.2. South Africa Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 9.4.1.3. South Africa Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 9.4.2. GCC 9.4.2.1. GCC Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 9.4.2.2. GCC Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 9.4.2.3. GCC Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 9.4.3. Rest Of MEA 9.4.3.1. Rest Of MEA Immunohistochemistry Market Size and Forecast, By Product(2023-2030) 9.4.3.2. Rest Of MEA Immunohistochemistry Market Size and Forecast, By Application(2023-2030) 9.4.3.3. Rest Of MEA Immunohistochemistry Market Size and Forecast, By End-User(2023-2030) 10. Company Profile: Key Players 10.1. F. Hoffman-La Roche AG 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview (Total Revenue, Segment Revenue, and Regional Revenue) 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Danaher Corporation 10.3. Agilent Technologies, Inc. 10.4. Merck KGaA 10.5. Bio-Rad Laboratories, Inc. 10.6. Bio-Techne Corporation 10.7. Abcam plc 10.8. Becton Dickinson and Company 10.9. PerkinElmer, Inc. 10.10. Takara Bio, Inc. 10.11. Thermo Fisher Scientific, Inc. 10.12. PHC Holdings Corporation 10.13. Cell Signaling Technology, Inc. 10.14. Bio SB, Inc. 10.15. Miltenyi Biotec 10.16. CANDOR Bioscience GmbH 10.17. Sakura Finetek Japan Co., Ltd. 10.18. Eagle Biosciences, Inc. 10.19. Biocare Medical, LLC 11. Key Findings 12. Analyst Recommendations 12.1. Attractive Opportunities for Players in the Immunohistochemistry Market 12.2. Future Outlooks 13. Immunohistochemistry Market: Research Methodology
